pMDT in Thoracic Surgery--------For the Baseline Investigation and Technical Preparation Stage

NCT03759275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2022-03-29

No results posted yet for this study

Summary

The risk of acute and chronic pain after thoracic surgery is high. The multi-disciplinary postoperative pain management strategy is the best way to control postoperative pain in thoracic surgery. Through nearly one year of experience in implementation of the pMDT in the thoracic surgery department of Peking University People's Hospital, the investigators have summarized the experience in multidisciplinary pain management and promoted this study in multi-centers across the country, hoping that this study can improve the current situation of acute pain management in patients after thoracic surgery, and at the same time, the deficiencies of this clinical protocol can be found out and improved.

Conditions

  • Pain, Postoperative

Interventions

OTHER

pMDT(Baseline Investigation)

The pMDT(Baseline Investigation) takes multi-model analgesia as the main technical means. Multimodal perioperative analgesia refers to the combination of analgesics, adjuvant drugs and analgesic techniques with different effects throughout the perioperative period to achieve the best curative effect of reducing postoperative acute and chronic pain.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER
  • Anhui Provincial Hospital

    collaborator OTHER_GOV
  • Southwest Hospital, China

    collaborator OTHER
  • Fujian Provincial Hospital

    collaborator OTHER
  • Hebei Tumor Hospital

    collaborator OTHER
  • Qianfoshan Hospital

    collaborator OTHER
  • General Hospital of Shenyang Military Region

    collaborator OTHER
  • Shanghai Chest Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • LanZhou University

    collaborator OTHER
  • Lanzhou University Second Hospital

    collaborator OTHER
  • Kunming General Hospital of PLA

    collaborator UNKNOWN
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • First Affiliated Hospital of Kunming Medical University

    collaborator OTHER
  • The People's Hospital of Gaozhou

    collaborator OTHER
  • Shanxi Provincial People's Hospital

    collaborator OTHER_GOV
  • Liaoning Cancer Hospital & Institute

    collaborator OTHER
  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • Hebei Medical University Fourth Hospital

    collaborator OTHER
  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Feng Yi · Peking University People's Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-08-31
Completion
2021-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03759275 on ClinicalTrials.gov